ID 1327 - Mleczko pszczele

PL: Mleczko pszczele
EN: Royal jelly
Pdf:

Oświadczenie (2)

1.3. Ograniczenie zapalenia (ID 1327, 1391)

The claimed effects are “immune system” and “anti-inflammatoire”. The Panel assumes that the target population is the general population. In the context of the proposed wording, the Panel assumes that the claimed effects refer to the reduction of inflammation.
Inflammation is a non-specific physiological response to tissue damage that is mediated by the immune system. Adequate inflammatory responses are of primary importance for the defence against injury of any origin. Changes in markers of inflammation such as various interleukins do not indicate a beneficial physiological effect per se.
Chronic inflammation is associated with a number of diseases, and under certain circumstances reducing levels of markers of inflammation might indicate a beneficial physiological effect.
Whether or not the reduction of inflammatory markers is considered to be beneficial depends on the context in which the claim is made. The Panel considers that no evidence has been provided in which context the claimed effect could be considered as a beneficial physiological effect.
The Panel concludes that a cause and effect relationship has not been established between the consumption of the food(s)/food constituent(s) which are the subject of the health claims and a beneficial physiological effect related to the reduction of inflammation.

Warunki i możliwe ograniczenia stosowania oświadczenia

Gelée Royale 1000mg/jour